Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision marker at the bottom was updated from v3.6.4 to v3.6.5, signaling a maintenance update to the Study Details page. This change reflects a small backend or content refresh rather than a substantive change to the trial information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a recent site update without changes to the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, reflecting an updated version of the page content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study page now shows revision v3.6.2, replacing v3.6.0, indicating a minor, non-content update to how the page is rendered or tracked.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status on the study page has been updated to indicate enrollment is closed ('No longer looking for participants'). New guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting was adjusted, with a new page revision version.SummaryDifference0.4%

- Check72 days agoChange DetectedThe page footer updated its revision number from v3.5.4 to v3.5.5, representing a small site update; no visible content changes to the study details or layout.SummaryDifference0.0%

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.